ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

MONICA SCANTLEBURY M.D.

At A Glance: This Prescriber in 2012

Endocrinology, Diabetes Metabolism

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,047Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 463

$48.6K Total Retail Price of All Prescriptions

Rank: 427 out of 463

202 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
100% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 202 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 13,724 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 49%.

Prescription Price

$3 was the average price of a prescription from this provider, compared to $131 among peers.

Prescriptions per Patient

70 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
ASPIRIN EC 592 580 1 98
ONCE DAILY 432 428 10 2 113
DOCUSIL 331 331 10 3 126
PANTOPRAZOLE SODIUM 266 264 4 105
SIMVASTATIN 255 237 5 7
METFORMIN HCL 243 243 6 3
METOPROLOL TARTRATE 224 224 7 31
VITAMIN D 220 220 8 149
PRAVASTATIN SODIUM 214 214 9 43
AMLODIPINE BESYLATE 212 209 10 12
ATORVASTATIN CALCIUM 199 199 11 10
ALENDRONATE SODIUM 170 161 12 22
CALCIUM 165 165 10 13 169
POLYETHYLENE GLYCOL 3350 164 163 14 142
PAIN RELIEVER 164 164 10 14 171
LISINOPRIL 161 161 16 15
FUROSEMIDE 158 150 17 25
HYDROCHLOROTHIAZIDE 156 148 18 26
WARFARIN SODIUM 150 150 19 70
ISOSORBIDE MONONITRATE ER 145 136 20 105
SENNO 132 132 10 21 185
FERROUS SULFATE 131 131 22 187
LEVOTHYROXINE SODIUM 123 114 23 1
METOPROLOL SUCCINATE 121 112 24 28
ARTIFICIAL TEARS 114 112 25 194
TAMSULOSIN HCL 114 114 25 67
MULTIVITAMINS 109 89 27 201
CETIRIZINE HCL 105 105 28 206
SINGULAIR 103 103 29 84
OMEPRAZOLE 102 102 30 27
NAMENDA 101 101 31 112
ASCORBIC ACID 98 98 10 32 210
FOLIC ACID 98 98 32 210
GLIPIZIDE 95 95 34 36
GABAPENTIN 95 95 34 48
OYSTER SHELL CALCIUM W-VIT D 95 95 34 213
JANUVIA 94 93 37 6
INSULIN SYRINGE 92 86 38 18
LOSARTAN POTASSIUM 91 83 39 20
ESCITALOPRAM OXALATE 83 83 40 103
NASONEX 81 81 41 179
LIDODERM 79 79 42 80
TRAMADOL HCL 78 75 43 85
NEXIUM 76 76 44 37
ATENOLOL 74 74 45 29
CLOPIDOGREL 74 66 45 64
MIRTAZAPINE 72 64 47 116
TACTINAL 71 66 10 48 222
PLAVIX 70 70 49 61
NIFEDIPINE ER 70 70 49 72
AMMONIUM LACTATE 69 63 51 87
NIFEDICAL XL 69 69 51 168
OXYCODONE-ACETAMINOPHEN 68 68 S2 53 226
POTASSIUM CHLORIDE 68 68 53 76
LACLOTION 65 65 55 230
DOCUSATE SODIUM 65 56 55 230
CALCIUM 600 + VIT D 63 63 57 234
BISACODYL 62 62 58 236
VITAMIN B-12 62 62 58 236
GLIPIZIDE XL 62 62 58 46
NITROSTAT 62 59 58 236
CARTIA XT 62 62 58 236
ENALAPRIL MALEATE 61 61 63 35
DONEPEZIL HCL 60 60 64 79
LEVETIRACETAM 60 48 64 241
DAILY VITE 60 60 64 241
LEXAPRO 59 59 67 184
FIBERCON 58 58 10 68 247
SPIRIVA 57 57 69 167
SILTUSSIN DM DAS COUGH FORMULA 55 55 10 70 253
LANTUS SOLOSTAR 55 55 70 4
RISPERIDONE 53 53 72 199
PROAIR HFA 53 53 72 138
ZOLPIDEM TARTRATE 53 53 72 44
LANTUS 52 52 75 16
CLOTRIMAZOLE 51 51 76 263
FLUTICASONE PROPIONATE 51 50 76 129
LATANOPROST 50 50 78 201
VITAMIN D2 50 42 78 73
CRESTOR 50 50 78 13
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.